EMBL Ventures GmbH
+49 (0) 6221 389 330
"Since their first investment, EMBL Ventures has played a constructive and positive role within Affectis. Providing their extensive network, supporting the company through the board of directors or bringing in new projects, we have developed a fruitful relationship."
Prof. Herbert Stadler; CEO, Affectis Pharmaceuticals, Munich (2002-2010)